The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1021 TALVITIN THIAMINE HCL 2.5 MG, NICOTINAMIDE 12.5 MG, PYRIDOXINE 0.75 MG, ASCORBIC 37.5 MG, CALCIUM PANTOTHENATE 2.5 MG,CYANOCOBALAMIN 0.015 MG, FOLIC ACIDE 0.0625 MG TABLET BLISTERPACK PREVENTION AND TREAMENT OF DEFICIENCIES OF MULTIPLE VITAMINS, ANOREXIA NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 09 L 0709/16 29-AUG-2023 28-AUG-2026 View
1022 TALVITINE VITAMIN A 5 000 IU, VITAMIN D 1000 IU, THIAMINE HCL 2.5 MG, VITAMIN B2 2.5 MG, PYRIDOXINE B6 0.75 MG, VITAMIN B12 1.5 MCG, VITAMIN E 2.5 MG, VITAMINC C 5MG, NIACIAMIDE 12.5 MG, DEXPANTHENOL 2.15 MG SYRUP BOTTLE PREVENTION AND TREAMENT OF DEFICIENCIES OF MULTIPLE VITAMINS, ANOREXIA NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 05 L 1351/25 27-MAY-2025 26-MAY-2030 View
1023 TENSON 20 ENALAPRIL MALEATE 20 MG TABLETS BLISTERS NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 12 L 0806/19 29-AUG-2023 28-AUG-2026 View
1024 TENSON 5 ENALAPRIL MALEATE 5 MG TABLETS BLISTERS NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 12 L 0793/19 11-SEP-2023 10-SEP-2026 View
1025 TEPOMAKS TEPOTINIB 225 MG TABLET BOTTLE TREATMENT OF ADULT PATIENT WITH METASTATIC NON SMALL CELL LUNG CANCER HARBORING MESENCHYMAL-EPITHELIAL TRANSITION EXON 14 SKIPPING ALTERRATIONS NULL FACTORY NO.2 FACTORY No.2 LAOS CERTIFICATE RELEASED 01 L 1057/24 31-JAN-2024 30-JAN-2027 View
1026 TOMESAL NICLOSAMIDE 500MG TABLET BLISTERPACK WITH AWEETENING FAVOURING AGENTS FOR ALL TYPES OF TAPEWORM INFESTATIONS NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 08 L 0124/95 24-JUN-2025 23-JUN-2030 View
1027 TRAMAKS 2 TRAMETINIB 2 MG TABLET BOTTLE BRAF V600E OR V660K MUTATION-POSITIVE UNRESECTABLE OR MEATASTATIC MELANOMA, BRAF V600EMUTATION-POSITIVE METASTATIC NSCLC NULL FACTORY NO.2 FACTORY No.2 LAOS CERTIFICATE RELEASED 12 L 1042/23 15-Dec-2023 14-Dec-2026 View
1028 TUCAMAKS TUCATINIB 150 MG TABLET BOTTLE IN COMBINATION WITH TRASTUZUMAB AND CAPECITABINE FOR TREATMENT OF ADULT PATIENTS WITH ADVANCE UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER, INCLUDING PATIENT WITH BRAIN METASTASE WHO HAVE RECEIVED ONE OR MORE PRIOR ANTI-HER2-BASED REGIMENTS IN THE METASTATIC SETTING. NULL FACTORY NO.2 FACTORY NO. 2 LAOS CERTIFICATE RELEASED 04 L 1334/25 07-APR-2025 06-APR-2030 View
1029 VALIVIUM DIAZEPAM 10MG INJECTION AMPOULES PSYCHONEUROSES, ANXIETY TENSION AND AUTONOMIC FUNCTIONAL DISORDERS NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 08 L 0134/95 31-JUL-2023 30-JUL-2026 View
1030 VELIUM 10 DIAZEPAM 10 MG TABLET BLISTERPACK used to treat anxiety disorders NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 04 L 1345/25 27-MAY-2025 26-MAY-2030 View
 
© 2014 ສະຫງວນລິຂະສິດໂດຍ ກົມອາຫານ ແລະ ຢາ, ກະຊວງສາທາລະນະສຸກ, ສປປລາວ.
ຕິດຕໍ່ ກອຢ      ອີເມວ      ເຂົ້າລະບົບ